Medtech companies directory 2026
Medical Device Companies in Singapore
The Health Sciences Authority licences devices and dealers. Esco is the local life-science and hospital-equipment manufacturer that export decks already know. Biosensors International is the Singapore-born interventional house now inside a larger group. Becton Dickinson runs a regional hub from the island; Siemens Healthineers’ SEA organisation sits here and covers accounts the cluster CMOs actually name. Parkway and the wider IHH system are the private buyer; NUHS and National University Hospital are the public academic door; SingHealth and NHG complete the cluster map. BioNixus fields those named cluster and Parkway desks, not a “ASEAN hospital” blend.
Updated September 2026 · HSA — Health Sciences Authority, medical device and dealer licensing as of September 2026 · 16 named accounts
HSA
Health Sciences Authority — Class A–D device and dealer licensing
3 clusters
SingHealth, NHG and NUHS — public buying systems that do not share one catalogue
IHH / Parkway
Private-hospital door that buys on a different clock from the clusters
SEA hub
Jurong and Tuas warehouses that feed brands into Malaysia, Indonesia and beyond
Named accounts
Top medical device companies in Singapore
| # | Company | HQ | Type | Device categories | Notes |
|---|---|---|---|---|---|
| 01 | HSA (Health Sciences Authority) | Singapore | Government | ||
| 02 | NUHS / National University Hospital procurement | Singapore | Government | ||
| 03 | SingHealth group procurement | Singapore | Government | ||
| 04 | Esco | Singapore | Local | ||
| 05 | Biosensors International | Singapore | Local | ||
| 06 | Becton Dickinson Singapore hub | Singapore | MNC | ||
| 07 | Siemens Healthineers SEA | Singapore | MNC | ||
| 08 | Parkway / IHH Singapore hospitals | Singapore | Operator | ||
| 09 | National Healthcare Group (NHG) procurement | Singapore | Government | ||
| 10 | Transmedic / specialist Singapore dealers | Singapore | Distributor | ||
| 11 | DKSH medical Singapore | Singapore | Distributor | ||
| 12 | Medtronic Singapore | Singapore | MNC | ||
| 13 | GE HealthCare Singapore | Singapore | MNC | ||
| 14 | Olympus Singapore | Singapore | MNC | ||
| 15 | MOH cluster capital overlay | Singapore | Government | ||
| 16 | National University Hospital (as named account) | Singapore | Operator |
Primary research
These are the medical device companies accounts we study in Singapore
Need account-level or SKU-level data for a brand in Singapore? BioNixus runs primary fieldwork — brand vs competitors, including the channels a dashboard averages away. Proposal ready within 48 hours of a brief.
Planning research in Singapore?
Primary research, market access & HEOR. Proposals within 48 hours.
How the market is structured
HSA class, cluster catalogue, Parkway desk
Local
Esco and Biosensors — Singapore-origin houses whose factories or origin stories already sit in cluster and regional cath-lab conversations.
- Esco
- Biosensors International
Multinational
BD, Siemens SEA, Medtronic, GE and Olympus seats that use the island as a cluster-facing and SEA-hub organisation.
- Becton Dickinson Singapore hub
- Siemens Healthineers SEA
- Medtronic Singapore
- GE HealthCare Singapore
- Olympus Singapore
Regional
Licensed dealers (Transmedic, DKSH and peers) that hold HSA dealer licences and cluster vendor codes for brands without a full field force.
Distributors & service partners
HSA as the class-and-dealer gate, three public clusters plus MOH envelopes, Parkway/IHH as the private door.
- HSA (Health Sciences Authority)
- NUHS / National University Hospital procurement
- SingHealth group procurement
- Parkway / IHH Singapore hospitals
- National Healthcare Group (NHG) procurement
- Transmedic / specialist Singapore dealers
- DKSH medical Singapore
- MOH cluster capital overlay
- National University Hospital (as named account)
What is moving
What is moving the medical device market in Singapore
Cluster catalogue fragmentation
SingHealth, NHG and NUHS do not share one list. A NUH evaluation that never reached SGH is a failed public launch, not a soft start.
Parkway capital speed versus cluster envelopes
IHH hospitals will take a premium SKU months before a cluster envelope opens; BioNixus splits those two clocks in every Singapore forecast.
SEA hub inventory versus island demand
Jurong and Tuas warehouses serve Malaysia and Indonesia as much as they serve NUH. Counting hub stock as Singapore hospital demand overstates the island.
HSA class upgrades and dealer-licence hygiene
Cluster biomedical engineers now ask for class and dealer numbers on the evaluation form; a regional HQ slide is not a substitute.
BioNixus fieldwork
How BioNixus studies medical device companies in Singapore
- SingHealth, NHG and NUHS catalogue walks treated as three public doors, never as one MOH buyer.
- HSA class-and-dealer number checks against the carton a cluster CSSD actually accepts.
- Parkway / IHH capital-desk interviews timed against cluster envelope calendars.
- Jurong and Tuas hub-stock splits so SEA warehouse volume is not counted as island hospital demand.
Questions
Frequently Asked Questions
How are medical devices registered in Singapore?
HSA classes them A to D and licences the dealer. The cluster biomedical engineer will ask for both numbers before the SKU joins an evaluation shortlist.
Who buys devices for public hospitals?
Three clusters — SingHealth, NHG and NUHS — plus a MOH shadow on capital envelopes. National University Hospital is a NUHS account, not the national buyer.
How does Parkway / IHH buy compared with the clusters?
Faster capital cycles, thinner catalogue discipline, more willingness to take a premium SKU the public list has not opened. It is a different commercial object.
Which Singapore-origin device names belong on a brief?
Esco for laboratory and hospital-adjacent equipment, Biosensors International for the interventional origin story, plus the island hubs of BD and Siemens SEA.
What does BioNixus study on Singapore device accounts?
HSA class-and-dealer traces, named cluster-catalogue reconstructions, Parkway desk interviews, and hub-versus-island inventory splits.
Is this a ranking of Singapore medtech share?
No. Names appear because they recur in BioNixus cluster and Parkway fieldwork; sequence is by role, not by revenue.
Sources
Data sources & methodology
This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Singapore. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.
Primary register: HSA — Health Sciences Authority, medical device and dealer licensing, consulted 2026-09-05. Company classification (Local / MNC / Regional / distributors & service partners) reflects ownership and role in Singapore, not size.
- HSA medical-device classification and dealer-licence guidance, consulted 2026
- MOH cluster and institution procurement notices; NUHS and NUH published descriptions
- Esco, Biosensors, BD and Siemens Healthineers published Singapore / SEA site descriptions
- BioNixus Singapore cluster and Parkway hospital fieldwork, 2023–2026
BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.
48-hour proposal
Need device-level competitive data in Singapore?
Installed base, procedure volumes, surgeon preference and tender outcomes by hospital — fielded across public and private operators.
Planning research in Singapore?
Primary research, market access & HEOR. Proposals within 48 hours.